NovoCure Limited (NASDAQ:NVCR)
Old Forum Content for NVCRMake a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- Wykeman: $NVCR running again
- ROSEY: @Wykeman $NVCR THANKS for mentioning. Do you know if drugs are used in addition to the magnetic field battery pack application?
- captron: $NVCR - This looks like a short squeeze to me. It has 14 days of short covering on the books. Long.
- DrScience: $NVCR And, I thought is was all a dream... DrScience: I'll take Biotech for $600, Alex... Alex: Answer: The Daily Double!! DrScience: I'll wager $810, Alex. Alex: And, the answer is: Novocure's Optune phase 3 trial results. DrScience: (Shaking head) I don't know, Alex. I was asleep at the wheel on this one. Alex: Oh! What's the opposite of an @woodman Bio-turd? ... A correct answer would have been good for a 70% gain.
- coldevinc: $NVCR People were talking about $24 being good buy points last month. What is everyone thinking now? Watching chart and reading you all.
- coldevinc: $NVCR coming back nicely
-4.99% $NVCR NovoCure Ltd 26.26 100
-4.92% $LABD Direxion Shares Ex 38.65 2730
-4.76% $ANY Sphere 3D Corp 1.30 20000
-3.85% $PLX Protalix BioTherap 0.75 5430
-2.20% $GGN GAMCO Global Gold 4.45 8900
-0.86% $BTX BioTime Inc 3.46 400
- coldevinc: $NVCR watching for a good entry. Waiting for a PB to mid 24's. Don't think that is going to happen.... ideas???
$NVCR Novocure Ltd 24.00 9.39%
$NUAN Nuance Communic 18.55 8.80%
$EBIX Ebix Inc 38.24 8.33%
$NYMT New York Mortgage. 6.05 8.23%
$MRNS Marinus Pharmace 5.50 7.84%
$CMCM Cheetah Mobile In 18.35 6.87%
$IDI Tiger Media Inc 11.00 6.49%
$TJX Tjx Cos. ...
- jetace: $NVCR it has gone above it's day 1 high per Dan's IPO strategy, bought some last week, novel cancer treatment using electric field technology, good results on some of the worst types of cancer
- jetace: $NVCR another leg up this morning, added to my position
|Stock Price||$USD 18.90|
NovoCure Ltd is a commercial stage oncology company. It is engaged in the development, manufacture and commercialization of tumor treating fields for the treatment of solid tumors.Request Video of NVCR
Already a member? Sign in here.
- February 22nd, 2018 - 2017 Q4 Earnings
- $USD 16.30 27.35%
- $USD 57.99 25.09%
- $USD 54.01 18.07%
- $USD 13.74 -35.47%
- $USD 18.06 -23.74%
- $USD 26.45 -21.27%
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 14 day FREE membership. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 51,500 stock analysis videos
- Access an ever expanding library (51,500) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Your Stock Market Mentor membership comes with a 14 day, no questions asked, 100% money back guarantee!